Price changes: Analysis of recent price changes of cabozantinib

Cabozantinib (Cabozantinib) is a targeted therapy drug that belongs to the category of multi-target tyrosine kinase inhibitors. It is designed to treat several types of cancer, including advanced renal cell carcinoma, thyroid cancer, and hepatocellular carcinoma.

Because cabozantinib has not yet obtained marketing approval in China, patients cannot directly purchase this drug in China. However, cabozantinib can be obtained through overseas channels, including purchasing original drugs and generic drugs. Original drugsare usually expensive. For example, in Japan and Europe, Original drugThe price of cabozantinib is about 30,000 to 40,000 yuan (the specific currency unit will be added according to the actual situation). Relatively speaking, the price of generic drugs is more affordable. For example, the price of generic drugs from Laos, India, Bangladesh and other places only ranges from a few hundred to several thousand yuan. It is worth noting that the ingredients of these original drugs and generic drugs are basically the same. Therefore, patients can choose the drug that suits them based on their financial situation and disease needs.

As a targeted therapy drug, cabozantinib’s mechanism of action is mainly by inhibiting multiple key signaling pathways, thereby inhibiting the growth, spread and angiogenesis of cancer cells. Cabozantinib mainly acts on multiple receptor tyrosine kinases (RTKs), including MET (hepatocyte growth factor receptor), VEGFR (vascular endothelial growth factor receptor) , RET (rearranged oncogene family receptor kinase), KIT (cytoplasmic tyrosine kinase) and AXL (axon-associated protein kinase), etc. By inhibiting the activity of these receptor tyrosine kinases, cabozantinib can effectively block the growth signaling of tumor cells, thereby inhibiting the growth and metastasis of tumor cells.

In general, cabozantinib is a targeted therapy that inhibits tumor cell growth and angiogenesis through multiple signaling pathways. It has shown promising efficacy in treating many types of cancer and provides an effective treatment option for patients with advanced cancer.